EAM
BNTX icon

Eschler Asset Management’s BioNTech BNTX Stock Holding History

Eschler Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,580
Closed -$353K – 66
2025
Q3 		$353K Buy
+3,580
New +$383K 0.26% 51
2023
Q1 		– Sell
-4,540
Closed -$682K – 66
2022
Q4 		$682K Buy
+4,540
New +$699K 1.29% 23
2022
Q3 		– Sell
-2,900
Closed -$432K – 39
2022
Q2 		$432K Buy
2,900
+450
+18% +$68.8K 0.88% 26
2022
Q1 		$418K Buy
+2,450
New +$412K 0.39% 32

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eschler Asset Management's BNTX Position: Q4 2025 in Review

Eschler Asset Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 3,580 shares — an estimated $353K sold.

Eschler Asset Management first reported a position in BNTX in Q1 2022 and held it in 4 quarters. The position peaked at $682K in Q4 2022. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Eschler Asset Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Eschler Asset Management sold 3,580 BioNTech shares in Q4 2025, an estimated $353K.
  • Eschler Asset Management first reported a position in BioNTech in Q1 2022 and held it in 4 quarters.
  • Eschler Asset Management's BioNTech position peaked at $682K in Q4 2022.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Eschler Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.